EW Revenue 2026

Annual and quarterly sales data for Edwards Lifesciences Corp

Latest Annual Revenue

$1.39B

2024-12-31

YoY Growth

+2.3%

vs. previous year

4-Year CAGR

2.3%

compound growth

Annual Revenue History

2024-12-31

$1.39B

YoY Growth

+2.3%

2024-09-30

$1.35B

YoY Growth

-1.1%

2024-06-30

$1.37B

YoY Growth

+3.0%

2024-03-31

$1.33B

YoY Growth

+5.0%

2023-12-31

$1.27B

Quarterly Revenue Breakdown

2025-09-30

$1.55B

2025-06-30

$1.53B

2025-03-31

$1.41B

2024-09-30

$1.35B

2024-06-30

$1.37B

2024-03-31

$1.33B

2023-09-30

$1.24B

2023-06-30

$1.30B

Revenue by Segment

Total Revenue$1.39B (100.0%)

Get Full EW Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is EW's revenue?

EW (Edwards Lifesciences Corp) reported $1.39 billion in revenue for 2024-12-31. This represents a 2.3% increase compared to the previous year.

How much revenue does EW make per year?

Edwards Lifesciences Corp generates approximately $1.39 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.

Is EW revenue growing?

Yes, EW's revenue is growing. The company achieved 2.3% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 2.3%.

What is EW's quarterly revenue?

EW reported $1.55 billion in revenue for the most recent quarter (2025-09-30). This is 1.4% higher than the previous quarter.

What are EW's revenue sources?

EW's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does EW compare to competitors in revenue?

EW generates $1.39 billion in annual revenue in the Healthcare sector. Compare EW to competitors using our stock comparison tool to see relative market share and growth rates.

What is EW's revenue per share?

Revenue per share for EW can be calculated by dividing annual revenue by shares outstanding. Visit our stock analysis page for detailed metrics.

Why is EW's revenue important for investors?

Revenue (also called sales or top-line) is the total income Edwards Lifesciences Corp generates from its operations. Revenue growth indicates business expansion and market share gains. For EW, tracking revenue trends helps investors understand the company's growth trajectory, pricing power, and market position in the Healthcare sector.

What affects EW's revenue growth?

Key factors affecting EW's revenue include: market demand, pricing strategy, competitive dynamics, product/service mix, geographic expansion, and macroeconomic conditions.

How to analyze EW's revenue quality?

To assess EW's revenue quality, consider: (1) Revenue consistency - is growth sustainable? (2) Revenue sources - diversified or concentrated? (3) Recurring vs one-time revenue - subscription models are more predictable. (4) Customer concentration - dependency on few customers. (5) Currency exposure for international operations.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories